September 16. The House Ways and Means Committee advanced the bipartisan Alzheimer’s Screening and Prevention Act. The bill would create a pathway for Medicare to consider coverage of early detection tests; it has not become law. Why it belongs here: It connects diagnostic progress with access and coverage. Distinguish evaluation of cognitive symptoms from screening people without symptoms.

Original source: Alzheimer’s Association policy update